The study compares the predictive value of fasting blood glucose (FBG) and 2-hour post-glucose (2h-BG) criteria for cardiovascular mortality. It analyzed data from 10 European cohort studies involving 22514 participants, with a median follow-up of 8.8 years. The study found that 2h-BG was a better predictor of all-cause and cardiovascular mortality than FBG alone. When both FBG and 2h-BG were considered together, the risk of mortality was significantly higher in individuals with diabetes based on 2h-BG criteria compared to those with normal 2h-BG levels. The largest number of excess deaths was observed in individuals with impaired glucose tolerance (IGT) but normal FBG levels. The study concluded that 2h-BG is a better predictor of mortality than FBG, and that the inclusion of 2h-BG significantly improves the prediction of mortality. The study also found that the 2-hour glucose criteria provided better discrimination for cardiovascular mortality than the fasting glucose criteria. The study highlights the importance of considering both FBG and 2h-BG in the diagnosis and management of diabetes, as they provide different prognostic information. The study was conducted as part of the DECODE Study Group, which aimed to evaluate the prognostic impact of new fasting glucose criteria for diabetes. The study found that the 2-hour glucose criteria were more accurate in predicting mortality than the fasting glucose criteria, and that the inclusion of both criteria improved the prediction of mortality. The study also found that individuals with IGT had a higher risk of mortality compared to those with normal glucose tolerance. The study concluded that the 2-hour glucose criteria are more accurate in predicting mortality than the fasting glucose criteria, and that the inclusion of both criteria improves the prediction of mortality. The study was published in the Archives of Internal Medicine in 2001.The study compares the predictive value of fasting blood glucose (FBG) and 2-hour post-glucose (2h-BG) criteria for cardiovascular mortality. It analyzed data from 10 European cohort studies involving 22514 participants, with a median follow-up of 8.8 years. The study found that 2h-BG was a better predictor of all-cause and cardiovascular mortality than FBG alone. When both FBG and 2h-BG were considered together, the risk of mortality was significantly higher in individuals with diabetes based on 2h-BG criteria compared to those with normal 2h-BG levels. The largest number of excess deaths was observed in individuals with impaired glucose tolerance (IGT) but normal FBG levels. The study concluded that 2h-BG is a better predictor of mortality than FBG, and that the inclusion of 2h-BG significantly improves the prediction of mortality. The study also found that the 2-hour glucose criteria provided better discrimination for cardiovascular mortality than the fasting glucose criteria. The study highlights the importance of considering both FBG and 2h-BG in the diagnosis and management of diabetes, as they provide different prognostic information. The study was conducted as part of the DECODE Study Group, which aimed to evaluate the prognostic impact of new fasting glucose criteria for diabetes. The study found that the 2-hour glucose criteria were more accurate in predicting mortality than the fasting glucose criteria, and that the inclusion of both criteria improved the prediction of mortality. The study also found that individuals with IGT had a higher risk of mortality compared to those with normal glucose tolerance. The study concluded that the 2-hour glucose criteria are more accurate in predicting mortality than the fasting glucose criteria, and that the inclusion of both criteria improves the prediction of mortality. The study was published in the Archives of Internal Medicine in 2001.